Author
University of California, San FranciscoORCID 0000-0001-9132-0496Unclaimed ORCID profile · follow to get notified of new preprints
7 papers
Recent·Most cited
Mark M. Painter, David B. Reeg, Naomi R. Douek…·E. John Wherry
The paper identifies persistently activated virus-specific CD8 T cells in long COVID patients, suggesting chronic antigen stimulation by SARS-CoV-2 or herpesvirus.
Shane D. Falcinelli, David P. Maison, Isaac Avila-Vargas…·Michael J. Peluso
The paper identifies a subset of HIV elite controllers with proteomic profiles similar to uninfected individuals, associated with lower viral reservoirs and protective HLA alleles.
Brian LaFranchi, David P. Maison, Joanna Vinden…·Timothy J. Henrich
This study uses multiomic and spatial profiling of colorectal tissue and blood to show that Long COVID is linked to immune dysregulation and viral persistence, with stronger signals in tissue than blood.
Mauro A. Garcia, Anna Farrell-Sherman, Beril Aydin…·Janet D'Angelo Siliciano
The paper identifies autologous neutralizing antibodies (aNAbs) as critical determinants of HIV-1 rebound after treatment interruption, defining quantitative limits on rebound-competent reservoirs.
Miguel Pesqueira, Rosalia de Necochea-Campion, Thomas Dalhuisen…·Steven P. LaRosa
The paper identifies increased mannosylation of extracellular vesicles in Long COVID plasma and shows GNA affinity resin can remove them, potentially rebalancing immune and tissue-repair networks.
Julia A. Wagner, Demi A. Sandel, Ravi K. Patel…·Rachel Lena Rutishauser
This study shows that bNAb-mediated HIV suppression is linked to increased immune activation compared to ART suppression, with unique transcriptional patterns in controllers.
Anna Farrell-Sherman, Walker Azam, Natalia de la Force…·Lillian B. Cohn
The paper identifies early immune responses preceding HIV rebound and links them to viral control outcomes in individuals discontinuing antiretroviral treatment.